SCHEMBL607157

SCHEMBL607157

[O-][n+]1cccc2cc(F)ccc21

nearest known ligand 0.45

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
CYP2A6 P11509 1/20 0.45
ATM Q13315 1/20 0.39
PPARG P37231 1/20 0.36
ACHE P22303 3/20 0.33
TDO2 P48775 1/20 0.33
AHR P35869 1/20 0.31
BCHE P06276 1/20 0.31
FLT3 P36888 1/20 0.30
HSP90AA1 P07900 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2107267 0.84 CYP1A2 (0.45) CYP1A2CYP2A6ATMACHETDO2
SCHEMBL9227699 0.78 ATM (0.40) ATMACHEHSP90AA1MAPTHTT
SCHEMBL3264399 0.76 MEN1 (0.47) CYP1A2ATMACHEHSP90AA1MAPT
SCHEMBL1826895 0.76 CYP2A6 (0.45) CYP2A6ATMACHEAHRHSP90AA1
SCHEMBL3732872 0.76 ATM (0.39) ATMACHEHSP90AA1MAPTHTT
SCHEMBL1771699 0.76 ALDH1A1 (0.45) ATMACHEHSP90AA1MAPTHTT
SCHEMBL2798405 0.76 KDM4E (0.45) CYP1A2CYP2A6ATMACHEMAPT
SCHEMBL369538 0.76 CYP2A6 (0.45) CYP1A2CYP2A6ATMACHEAHR
SCHEMBL20996058 0.76 ATM (0.39) ATMACHEHSP90AA1MAPTHTT
SCHEMBL11822605 0.74 CA3 (0.31) CYP1A2CYP2A6ATMACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1172670-C Liposome composition for improved drug retention 2004-10-27 CN claimed
EP-1083881-B1 LIPOSOME COMPOSITIONs containing a quinolone derivative AND their use as antibacterial agents ALZA CORP (US) 2004-08-25 EP claimed
EP-0825852-B1 LIPOSOME DRUG-LOADING METHOD AND COMPOSITION YISSUM RES DEV CO (IL) 2004-07-07 EP claimed
EP-1176962-B1 LIPOSOME COMPOSITIONS FOR IMPROVED DRUG RETENTION ALZA CORP (US) 2004-02-11 EP claimed
CN-1351495-A Liposome composition for improved drug retention ALZA CORP (US) 2002-05-29 CN claimed
EP-1176962-A2 LIPOSOME COMPOSITIONS FOR IMPROVED DRUG RETENTION Alza Corporation (US) 2002-02-06 EP claimed
EP-1083881-A2 LIPOSOME COMPOSITION AND METHOD FOR ADMINISTERING A QUINOLONE ALZA Corporation (US) 2001-03-21 EP claimed
WO-2000066126-A2 LIPOSOME COMPOSITIONS FOR IMPROVED DRUG RETENTION ALZA CORPORATION (US) 2000-11-09 WO claimed
EP-0366641-B1 Novel antimicrobial quinolonyl lactam esters NORWICH EATON PHARMA (US) 2000-07-05 EP claimed
EP-0997466-A1 Novel antimicrobial lactam-quinolones PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 2000-05-03 EP claimed
US-5434147-A Bactericides PROCTOR & GAMBLE PHARMACEUTICALS, INC. (US) 1995-07-18 US claimed
US-5273973-A Carbapenicillins NORWICH EATON PHARMACEUTICALS, INC. (US) 1993-12-28 US claimed
EP-0525057-A4 ANTIMICROBIAL QUINOLONYL LACTAMS 1993-04-07 EP claimed
EP-0525057-A1 ANTIMICROBIAL QUINOLONYL LACTAMS Norwich Eaton Pharmaceuticals, Inc. (US) 1993-02-03 EP claimed
US-5180719-A Microbiocides NORWICH EATON PHARMACEUTICALS, INC. (US) 1993-01-19 US claimed
WO-1991016327-A1 ANTIMICROBIAL QUINOLONYL LACTAMS NORWICH EATON PHARMACEUTICALS, INC. (US) 1991-10-31 WO claimed
WO-1990004594-A1 NOVEL ANTIMICROBIAL QUINOLONYL LACTAM ESTERS NORWICH EATON PHARMACEUTICALS, INC. (US) 1990-05-03 WO claimed
EP-0366193-A2 Novel antimicrobial quinolonyl lactams Norwich Eaton Pharmaceuticals, Inc. (US) 1990-05-02 EP claimed
EP-0366641-A2 Novel antimicrobial quinolonyl lactam esters Norwich Eaton Pharmaceuticals, Inc. (US) 1990-05-02 EP claimed
EP-0366189-A2 Novel antimicrobial lactam-quinolones Norwich Eaton Pharmaceuticals, Inc. (US) 1990-05-02 EP claimed